Best Doctors

bestdoctors.com

The Best Doctors suite of expert medical services are part of the Teladoc Health family, helping patients get answers for their healthcare needs. The trusted expert resource brings confidence to care decisions by connecting members and their treating physicians with a network of the top 50,000 world-renowned experts in 450 medical subspecialties. From confirming the right diagnosis and treatment plan, to helping solve the most critical and costly conditions in healthcare, Best Doctors’ innovative services deliver patient-centric, expert advice that empowers members and their physicians with actionable information.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PIRAMAL PHARMA SOLUTIONS TO ACQUIRE MANUFACTURING FACILITY OF G&W LABORATORIES IN US

livemint | June 20, 2020

news image

Piramal Enterprises Ltd's Pharma Solutions business, a contract development and manufacturing organization, on Saturday announced that it has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Pennsylvania, USA, for $17.5 million. The all-cash deal is subject to customary pre-closing conditions. According to the terms of the agreement, Piramal Enterprises, through one of its affiliates, would acquire at clo...

Read More

Research

PLURISTEM ENTERS COLLABORATION WITH PHARMACEUTICAL COMPANY INNOVARE R&D TO EXPAND PLURISTEM’S ARDS ASSOCIATED WITH COVID-19 PROGRAM TO MEXICO

Pluristem | December 30, 2020

news image

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a main regenerative medication organization building up a foundation of novel natural helpful items, reported today it has gone into a coordinated effort concurrence with Mexican drug organization Innovare R&D to extend its continuous clinical program of PLX cells in the treatment of Acute Respiratory Distress Syndrome (ARDS) related with COVID-19 in Mexico. The Phase II investigation in Mexico is dependent upon the endorsement of neighb...

Read More

Business Insights

MEDAVAIL ANNOUNCES PRICING OF $50 MILLION PRIVATE PLACEMENT

MedAvail | April 01, 2022

news image

MedAvail Holdings, Inc. a technology-enabled retail pharmacy company, announced it has entered into a definitive securities purchase agreement for the sale of common stock and warrants to purchase common stock in a private placement with certain institutional and other accredited investors for gross proceeds to MedAvail of $50 million, before deducting placement agent commissions and other offering expenses. Pursuant to the terms of the securities purchase agreement and following ...

Read More

GILEAD LAUNCHES TWO PHASE III TRIALS OF REMDESIVIR FOR COVID-19

BioSpace: | February 27, 2020

news image

Gilead Sciences, based in Foster City, California, announced it will launch two Phase III clinical trials of its investigational antiviral drug remdesivir in adults diagnosed with COVID-19, the disease caused by the novel coronavirus. The outbreak began in China in December and has since spread through much of the rest of the world, with most cases concentrated in Asia. The current number of confirmed cases worldwide is greater than 81,400 with a total death count of 2,770. The first cases of co...

Read More
news image

PIRAMAL PHARMA SOLUTIONS TO ACQUIRE MANUFACTURING FACILITY OF G&W LABORATORIES IN US

livemint | June 20, 2020

Piramal Enterprises Ltd's Pharma Solutions business, a contract development and manufacturing organization, on Saturday announced that it has entered into an agreement with G&W Laboratories Inc. to acquire its solid oral dosage drug product manufacturing facility located in Pennsylvania, USA, for $17.5 million. The all-cash deal is subject to customary pre-closing conditions. According to the terms of the agreement, Piramal Enterprises, through one of its affiliates, would acquire at clo...

Read More
news image

Research

PLURISTEM ENTERS COLLABORATION WITH PHARMACEUTICAL COMPANY INNOVARE R&D TO EXPAND PLURISTEM’S ARDS ASSOCIATED WITH COVID-19 PROGRAM TO MEXICO

Pluristem | December 30, 2020

Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a main regenerative medication organization building up a foundation of novel natural helpful items, reported today it has gone into a coordinated effort concurrence with Mexican drug organization Innovare R&D to extend its continuous clinical program of PLX cells in the treatment of Acute Respiratory Distress Syndrome (ARDS) related with COVID-19 in Mexico. The Phase II investigation in Mexico is dependent upon the endorsement of neighb...

Read More
news image

Business Insights

MEDAVAIL ANNOUNCES PRICING OF $50 MILLION PRIVATE PLACEMENT

MedAvail | April 01, 2022

MedAvail Holdings, Inc. a technology-enabled retail pharmacy company, announced it has entered into a definitive securities purchase agreement for the sale of common stock and warrants to purchase common stock in a private placement with certain institutional and other accredited investors for gross proceeds to MedAvail of $50 million, before deducting placement agent commissions and other offering expenses. Pursuant to the terms of the securities purchase agreement and following ...

Read More
news image

GILEAD LAUNCHES TWO PHASE III TRIALS OF REMDESIVIR FOR COVID-19

BioSpace: | February 27, 2020

Gilead Sciences, based in Foster City, California, announced it will launch two Phase III clinical trials of its investigational antiviral drug remdesivir in adults diagnosed with COVID-19, the disease caused by the novel coronavirus. The outbreak began in China in December and has since spread through much of the rest of the world, with most cases concentrated in Asia. The current number of confirmed cases worldwide is greater than 81,400 with a total death count of 2,770. The first cases of co...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us